Skip to content

Sleep Disturbances in Dermatology Patients

Sleep Disturbances in Dermatology Patients- a Survey

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03903263
Enrollment
624
Registered
2019-04-04
Start date
2018-09-21
Completion date
2019-01-31
Last updated
2019-04-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Disorder

Keywords

dermatologic disease

Brief summary

This study is to investigate sleep disorders in patients with dermatologic diseases by taking into consideration dermatologic (itch, pain) and non- dermatologic (medication, depression) factors.

Interventions

DIAGNOSTIC_TESTsurvey on sleep disorders

self-administered patient questionnaire regarding the different aspects of sleep disorders in patients with dermatologic diseases

Sponsors

University Hospital, Basel, Switzerland
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Outpatients of the dermatologic university clinic

Exclusion criteria

* Insufficient knowledge of German language * Illiteracy

Design outcomes

Primary

MeasureTime frameDescription
Regensburg Insomnia Scale (RIS)single time point assessment at baselineSelf-rating scale: Five items cover quantitative and qualitative sleep parameters: Sleep latency (1), sleep duration (2), sleep continuity (3), early awakening (4) and sleep depth (5). Four items cover the psychological aspects of psychophysiological insomnia (PI), such as the experience of sleepless nights (6), focussing on sleep (7), fear of insomnia (8), and daytime fitness (9), one item covers sleep medication (10). A 5-step Likert scale was provided for response.The total score ranges from 0 to 40 points (score from 0-12 points considered as normal and a higher score as indicative of PI symptoms).

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026